1. Home
  2. Tofogliflozin

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

Tofogliflozin

OC[C@H]1O[C@]2(OCc3c2cc(cc3)Cc2ccc(cc2)CC)[C@@H]([C@H]([C@H]1O)O)O Request for Quotation
Chemical Name: Tofogliflozin
CAS Number: 903565-83-3
Product Number: AG00GU9J(AGN-PC-0WAKQA)
Synonyms:
MDL No:
Molecular Formula: C22H26O6
Molecular Weight: 386.4382

Identification/Properties

Computed Properties
Molecular Weight:
386.444g/mol
XLogP3:
1.5
Hydrogen Bond Donor Count:
4
Hydrogen Bond Acceptor Count:
6
Rotatable Bond Count:
4
Exact Mass:
386.173g/mol
Monoisotopic Mass:
386.173g/mol
Topological Polar Surface Area:
99.4A^2
Heavy Atom Count:
28
Formal Charge:
0
Complexity:
521
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
5
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


Tofogliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is a valuable chemical reagent utilized in the field of chemical synthesis. Its unique mechanism of action in inhibiting the reabsorption of glucose in the kidneys has paved the way for its application in various synthetic pathways. In chemical synthesis, Tofogliflozin can serve as a key building block or reagent in the preparation of glucose analogs and derivatives. By incorporating Tofogliflozin into synthetic routes, chemists can modify the structure of glucose molecules to create novel compounds with potential therapeutic applications. Additionally, the ability of Tofogliflozin to selectively target SGLT2 receptors makes it a valuable tool in the design of drug candidates for the treatment of diabetes and related metabolic disorders.Furthermore, the presence of functional groups in Tofogliflozin offers opportunities for further derivatization through organic reactions, enabling the synthesis of diverse chemical compounds with enhanced properties. Its utility in chemical synthesis extends beyond diabetes research, with potential applications in the development of pharmaceuticals, agrochemicals, and materials science.Overall, the incorporation of Tofogliflozin in chemical synthesis provides a strategic approach to designing new molecules with improved bioactivity and specificity, opening up possibilities for innovative drug discovery and material design strategies.